Literature DB >> 11576233

An in vitro study of ovarian atypical proliferating (borderline) serous tumors.

C. van Haaften-Day1, P. Russell, S. Davies, S. Brammah-Carr.   

Abstract

Seven human serous ovarian atypically proliferating tumors (tumors of borderline malignancy) were grown in primary culture and compared morphologically with established cell lines derived from serous carcinomas (stage III-IV). Several parameters were investigated in order to establish the place of these tumors in a neoplastic spectrum between benign and frankly malignant serous neoplasms. The atypically proliferating tumors showed serous features, including prominent microvilli and multiple cilia, similar to those found in the malignant serous cells. DNA flow cytometric studies of the atypically proliferating tumors showed them to be diploid. Keratins were strongly expressed immunohistochemically by all the atypically proliferating tumors. Vimentin was also detected in six of the original tumors but only in one primary culture. The capacity to culture and study cells which represent possible intermediate stages in the evolution of ovarian malignancy may prove useful as an in vitro model for this disease.

Entities:  

Year:  1992        PMID: 11576233     DOI: 10.1046/j.1525-1438.1992.02010041.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  3 in total

1.  Weapons ovarian epithelial tumors may use in immune escape: an immunohistochemical correlational study.

Authors:  Eiman Adel Hasby
Journal:  Pathol Oncol Res       Date:  2011-12-08       Impact factor: 3.201

2.  Characterization of an HPV-negative cell line (FR-CAR) derived from a cervical squamous intraepithelial lesion.

Authors:  C van Haaften-Day; B Rose; C Thompson; R Lukeis; P Russell
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-10       Impact factor: 2.416

3.  Potent cytotoxic effects of Calomeria amaranthoides on ovarian cancers.

Authors:  Caroline van Haaften; Colin C Duke; Arij M Weerheim; Nico Pm Smit; Paul Mm van Haard; Firouz Darroudi; Baptist Jmz Trimbos
Journal:  J Exp Clin Cancer Res       Date:  2011-03-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.